What is the appropriate management for a patient with dengue infection presenting with warning signs?

Management of Dengue with Warning Signs

Patients with dengue and warning signs require hospital admission for close monitoring and judicious intravenous fluid resuscitation, as this represents the critical phase where plasma leakage can rapidly progress to shock and death if not managed appropriately. 1

Risk Stratification and Admission Criteria

• All patients with warning signs should be hospitalized for observation and management, as the absence of warning signs has a negative predictive value of 91-100% for severe disease, but their presence indicates significant risk of progression 2
• Warning signs include: abdominal pain or tenderness, persistent vomiting, clinical fluid accumulation (ascites, pleural effusion), mucosal bleeding, lethargy/restlessness, liver enlargement >2 cm, and rising hematocrit with rapid platelet decline 1, 3
• The window from onset of warning signs to severe illness is typically within one day in 51.3% of cases who progress, making hospital monitoring essential 2

Fluid Management Strategy

Crystalloids are the initial fluid of choice and represent the cornerstone of management during the critical phase 1:

• Begin with isotonic crystalloid solutions (normal saline or Ringer's lactate)
• Monitor hematocrit levels closely - rising hematocrit indicates plasma leakage and need for continued fluid support 1
• Adjust fluid rates based on clinical response, vital signs, urine output, and serial hematocrit measurements
• Judicious fluid resuscitation is critical - both under-resuscitation (leading to shock) and over-resuscitation (causing fluid overload) must be avoided 1

Monitoring Requirements

Close monitoring during hospitalization should include 1, 3:

• Serial complete blood counts with hematocrit and platelet counts
• Vital signs monitoring for early shock detection (tachycardia, narrowing pulse pressure, hypotension)
• Urine output measurement
• Assessment for bleeding manifestations
• Evaluation for organ involvement (hepatic, cardiac, neurologic, pancreatic)

Platelet Transfusion Guidelines

• Prophylactic platelet transfusion is NOT recommended 1
• Platelet transfusion is indicated for:
  • Active severe bleeding with thrombocytopenia
  • Platelet count <10,000/mm³ (severe bleeding is universal at this threshold) 3
• Females may require transfusion at higher platelet counts than males 3
• Only 7-11% of patients with warning signs ultimately require platelet transfusion 3

Organ-Specific Complications

Monitor and manage specific organ involvement 1, 3:

• Hepatic involvement is frequent - monitor liver enzymes and coagulation parameters
• Myocarditis, encephalitis, and pancreatitis are less common but require specific management when present
• Secondary hemophagocytic lymphohistiocytosis is a potentially fatal complication requiring recognition and treatment with steroids or intravenous immunoglobulin 1

Common Pitfalls to Avoid

• Do not discharge patients with warning signs - even if they appear stable, as deterioration can occur rapidly within 24 hours 2
• Avoid excessive fluid administration - this can lead to fluid overload and respiratory compromise 1
• Do not transfuse platelets prophylactically based solely on platelet count without bleeding 1
• Screen for coinfections (malaria, scrub typhus, enteric fever) which can complicate management 3

Expected Outcomes

With appropriate protocolized management:

• Case fatality rate for dengue with warning signs can be reduced to approximately 1.3% or lower 3
• Most patients recover with supportive care alone
• The critical phase typically lasts 24-48 hours, after which patients enter the recovery phase 4